Showing results (191-200 of 223) with videos related to
Sort By:
Pageof 23
AIDS Research and Human Retroviruses|June 22, 2023
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control StudyFrancesca Lombardi, Elena Bruzzesi, Yagai Romeo Bouba, et al.Medicine|July 22, 2016
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort studyEmanuele Focà, Massimiliano Fabbiani, Mattia Prosperi, et al.Current HIV Research|July 16, 2009
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patientsAnnalisa Saracino, Laura Monno, Alessandra Tartaglia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 2, 2022
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized TrialJosep M Llibre, Carlos Brites, Chien-Yu Cheng, et al.International Journal of Antimicrobial Agents|January 12, 2024
Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohortRoberta Gagliardini, Alessandro Tavelli, Stefano Rusconi, et al.Plos One|September 16, 2016
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral TreatmentGiuseppe Lapadula, Davide Paolo Bernasconi, Salvatore Casari, et al.Mediterranean Journal of Hematology and Infectious Diseases|June 16, 2015
Bacterial Epidemiology and Antimicrobial Resistance in the Surgery Wards of a Large Teaching Hospital in Southern ItalySilvano Esposito, Renato Gioia, Giuseppe De Simone, et al.The Journal of Infectious Diseases|January 22, 2014
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 studyAntonella Castagna, Franco Maggiolo, Giovanni Penco, et al.Plos One|September 28, 2019
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study)Cristina Mussini, Enrica Roncaglia, Vanni Borghi, et al.Expert Review of Anti-Infective Therapy|October 15, 2020
Enhancing care for people living with HIV: current and future monitoring approachesFranco Maggiolo, Alessandra Bandera, Stefano Bonora, et al.Pageof 23